The decision on procuring the right COVID-19 vaccine depends on
multiple factors, including safety, price and ease of deployment, the
scientists added, pitching for a preventive like the one being
developed by US firm Novavax that can be stored at lower temperatures
rather than those developed from mRNA or viral vectors.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/protein-based-covid-19-vaccine-candidates-would-be-more-suitable-for-india-scientists-say/articleshow/79279485.cms
No comments:
Post a Comment